Skip to main content

Paroxysmal Dyskinesias

  • Chapter
  • First Online:
Movement Disorders Curricula

Abstract

Paroxysmal dyskinesias are a rare heterogeneous group of conditions manifesting as abnormal involuntary movements that recur episodically and last for only a brief duration [1, 2]. Paroxysmal dyskinesias can broadly be classified to primary or idiopathic and secondary. An overview of the secondary forms is presented in Table 32.1 [3, 4]. However, in this chapter we will only review the main forms of genetically determined paroxysmal dyskinesias.

Received: September 18th, 2014.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 149.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fahn S. The paroxysmal dyskinesias. In: Marsden CD, Fahn S, editors. Movement disorders. Oxford: Butterworth Heinemann Ltd; 1994. p. 310–45.

    Google Scholar 

  2. Bhatia KP. Paroxysmal dyskinesias. Mov Disord. 2011;26(6):1157–65.

    Article  PubMed  Google Scholar 

  3. Blakeley J, Jankovic J. Secondary causes of paroxysmal dyskinesia. Adv Neurol. 2002;89:401–20.

    PubMed  Google Scholar 

  4. Blakeley J, Jankovic J. Secondary paroxysmal dyskinesias. Mov Disord. 2002;17(4):726–34.

    Article  PubMed  Google Scholar 

  5. Loher TJ, Krauss JK, Burgunder JM, Taub E, Siegfried J. Chronic thalamic stimulation for treatment of dystonic paroxysmal nonkinesigenic dyskinesia. Neurology. 2001;56(2):268–70.

    Article  CAS  PubMed  Google Scholar 

  6. Mirsattari SM, Berry ME, Holden JK, Ni W, Nath A, Power C. Paroxysmal dyskinesias in patients with HIV infection. Neurology. 1999;52(1):109–14.

    Article  CAS  PubMed  Google Scholar 

  7. Kertesz A. Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology. 1967;17:680–90.

    Article  CAS  PubMed  Google Scholar 

  8. Bruno MK, Hallett M, Gwinn-Hardy K, Sorensen B, Considine E, Tucker S, Lynch DR, Mathews KD, Swoboda KJ, Harris J, Soong BW, Ashizawa T, Jankovic J, Renner D, Fu YH, Ptacek LJ. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology. 2004;63(12):2280–7.

    Article  CAS  PubMed  Google Scholar 

  9. Lotze T, Jankovic J. Paroxysmal kinesigenic dyskinesias. Semin Pediatr Neurol. 2003;10(1):68–79.

    Article  CAS  PubMed  Google Scholar 

  10. Yamada K, Goto S, Soyama N, Shimoda O, Kudo M, Kuratsu J, Murase N, Kaji R. Complete suppression of paroxysmal nonkinesigenic dyskinesia by globus pallidus internus pallidal stimulation. Mov Disord. 2006;21(4):576–9.

    Article  PubMed  Google Scholar 

  11. Groffen AJ, Klapwijk T, van Rootselaar AF, Groen JL, Tijssen MA. Genetic and phenotypic heterogeneity in sporadic and familial forms of paroxysmal dyskinesia. J Neurol. 2013;260(1):93–9.

    Article  PubMed  Google Scholar 

  12. Valente EM, Spacey SD, Wali GM, Bhatia KP, Dixon PH, Wood NW, Davis MB. A second paroxysmal kinesigenic choreoathetosis locus (EKD2) mapping on 16q13-q22.1 indicates a family of genes which give rise to paroxysmal disorders on human chromosome 16. Brain. 2000;123(Pt 10):2040–5.

    Article  PubMed  Google Scholar 

  13. Alemdar M, Iseri P, Selekler M, Komsuoğlu SS. Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia. Clin Neuropharmacol. 2007;30(4):241–4.

    PubMed  Google Scholar 

  14. Tsao CY. Effective treatment with oxcarbazepine in paroxysmal kinesigenic choreoathetosis. J Child Neurol. 2004;19(4):300–1.

    Article  PubMed  Google Scholar 

  15. Uberall MA, Wenzel D. Effectiveness of lamotrigine in children with paroxysmal kinesigenic choreoathetosis. Dev Med Child Neurol. 2000;42(10):699–700.

    Article  CAS  PubMed  Google Scholar 

  16. Mount LA, Reback S. Familial paroxysmal choreoathetosis. Arch Neurol Psychol. 1940;44:841–7.

    Article  Google Scholar 

  17. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol. 1995;38:571–9.

    Article  CAS  PubMed  Google Scholar 

  18. Bhatia KP. The paroxysmal dyskinesias. J Neurol. 1999;246(3):149–55.

    Article  CAS  PubMed  Google Scholar 

  19. Bruno MK, Lee HY, Auburger GW, Friedman A, Nielsen JE, Lang AE, Bertini E, Van Bogaert P, Averyanov Y, Hallett M, Gwinn-Hardy K, Sorenson B, Pandolfo M, Kwiecinski H, Servidei S, Fu YH, Ptácek L. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology. 2007;68(21):1782–9.

    Article  CAS  PubMed  Google Scholar 

  20. Ghezzi D, Viscomi C, Ferlini A, Gualandi F, Mereghetti P, DeGrandis D, Zeviani M. Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. Hum Mol Genet. 2009;18(6):1058–64.

    Article  CAS  PubMed  Google Scholar 

  21. Du W, Bautista JF, Yang H, Diez-Sampedro A, You SA, Wang L, Kotagal P, Lüders HO, Shi J, Cui J, Richerson GB, Wang QK. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat Genet. 2005;37(7):733–8.

    Article  CAS  PubMed  Google Scholar 

  22. Browne DL, Gancher ST, Nutt JG, Brunt ER, Smith EA, Kramer P, Litt M. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet. 1994;8(2):136–40.

    Article  CAS  PubMed  Google Scholar 

  23. Spacey SD, Adams PJ, Lam PC, Materek LA, Stoessl AJ, Snutch TP, Hsiung GY. Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia. Neurology. 2006;66(10):1588–90.

    Article  CAS  PubMed  Google Scholar 

  24. Unterberger I, Trinka E. Diagnosis and treatment of paroxysmal dyskinesias revisited. Ther Adv Neurol Dis. 2008;1(2):4–11.

    Article  Google Scholar 

  25. Huang YG, Chen YC, Du F, Li R, Xu GL, Jiang W, Huang J. Topiramate therapy for paroxysmal kinesigenic choreoathetosis. Mov Disord. 2005;20(1):75–7.

    Article  CAS  PubMed  Google Scholar 

  26. Karakurum B, Karatas M, Yildirim T. Risperidone as an alternative treatment for paroxysmal kinesigenic dyskinesia. Neurol Sci. 2003;24(2):92–3.

    CAS  PubMed  Google Scholar 

  27. Jankovic J, Demirkiran M. Classification of paroxysmal dyskinesias and ataxias. Adv Neurol. 2002;89:387–400.

    PubMed  Google Scholar 

  28. Lance JW. Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol. 1977;2:285–93.

    Article  CAS  PubMed  Google Scholar 

  29. Bhatia KP, Soland VL, Bhatt MH, Quinn NP, Marsden CD. Paroxysmal exercise-induced dystonia: eight new sporadic cases and a review of the literature. Mov Disord. 1997;12:1007–12.

    Article  CAS  PubMed  Google Scholar 

  30. Pearson TS, Akman C, Hinton VJ, Engelstad K, De Vivo DC. Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep. 2013;13(4):342.

    Article  PubMed  Google Scholar 

  31. Brockmann K. Episodic movement disorders: from phenotype to genotype and back. Curr Neurol Neurosci Rep. 2013;13(10):379.

    Article  PubMed  Google Scholar 

  32. Brockmann K. The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev. 2009;31(7):545–52.

    Article  PubMed  Google Scholar 

  33. Guerrini R, Bonanni P, Nardocci N, Parmeggiani L, Piccirilli M, De Fusco M, Aridon P, Ballabio A, Carrozzo R, Casari G. Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer’s cramp: delineation of the syndrome and gene mapping to chromosome 16p12-11.2. Ann Neurol. 1999;45(3):344–52.

    Article  CAS  PubMed  Google Scholar 

  34. Weber YG, Storch A, Wuttke TV, Brockmann K, Kempfle J, Maljevic S, Margari L, Kamm C, Schneider SA, Huber SM, Pekrun A, Roebling R, Seebohm G, Koka S, Lang C, Kraft E, Blazevic D, Salvo-Vargas A, Fauler M, Mottaghy FM, Münchau A, Edwards MJ, Presicci A, Margari F, Gasser T, Lang F, Bhatia KP, Lehmann-Horn F, Lerche H. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest. 2008;118(6):2157–68.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Panagiotis Zis MD, PhD or Davide Martino PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Wien

About this chapter

Cite this chapter

Zis, P., Martino, D., Tamburini, T. (2017). Paroxysmal Dyskinesias. In: Falup-Pecurariu, C., Ferreira, J., Martinez-Martin, P., Chaudhuri, K. (eds) Movement Disorders Curricula. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1628-9_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1628-9_32

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1627-2

  • Online ISBN: 978-3-7091-1628-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics